Source:http://linkedlifedata.com/resource/pubmed/id/15552270
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2004-11-19
|
pubmed:abstractText |
There is evidence that angiogenesis plays an important role in the progression of multiple myeloma (MM). Hepatocyte growth factor (HGF) and tumor necrosis factor-alpha (TNF-alpha) are cytokines that potently stimulate angiogenesis. We evaluated the microvascular density (MVD) of bone marrow biopsies (after immunostaining with anti-CD34 antibodies) and serum levels of HGF and TNF-alpha in 43 patients with newly diagnosed MM. Twenty-four of these patients reached a plateau phase after treatment and were reevaluated for MVD, HGF and TNF-alpha. MVD values and serum levels of HGF and TNF-alpha were elevated in newly diagnosed MM patients in comparison with healthy controls. Pre-treatment MVD, HGF and TNF-alpha increased with advancing stage of MM disease. In patients reaching the plateau phase, a significant reduction in MVD, HGF and TNF-alpha levels occurred. A positive correlation was noted between pre-treatment MVD and serum levels of TNF-alpha and lactic dehydrogenase but not with HGF. However, HGF strongly correlated with beta2-microglobulin (beta2M), TNF-alpha and lactate dehydrogenase (LDH). We conclude that angiogenesis in MM, as expressed by the bone marrow MVD and the serum levels of angiogenic molecules such as HGF and TNF-alpha, increases with advancing clinical stage and decreases after effective chemotherapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenic Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Cytokines,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatocyte Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/L-Lactate Dehydrogenase,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/beta 2-Microglobulin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1434-6621
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1122-6
|
pubmed:meshHeading |
pubmed-meshheading:15552270-Adult,
pubmed-meshheading:15552270-Aged,
pubmed-meshheading:15552270-Angiogenic Proteins,
pubmed-meshheading:15552270-Bone Marrow,
pubmed-meshheading:15552270-Cytokines,
pubmed-meshheading:15552270-Hepatocyte Growth Factor,
pubmed-meshheading:15552270-Humans,
pubmed-meshheading:15552270-L-Lactate Dehydrogenase,
pubmed-meshheading:15552270-Male,
pubmed-meshheading:15552270-Middle Aged,
pubmed-meshheading:15552270-Multiple Myeloma,
pubmed-meshheading:15552270-Neovascularization, Pathologic,
pubmed-meshheading:15552270-Tumor Markers, Biological,
pubmed-meshheading:15552270-Tumor Necrosis Factor-alpha,
pubmed-meshheading:15552270-Vascular Endothelial Growth Factors,
pubmed-meshheading:15552270-beta 2-Microglobulin
|
pubmed:year |
2004
|
pubmed:articleTitle |
Bone marrow microvascular density and angiogenic growth factors in multiple myeloma.
|
pubmed:affiliation |
Department of Hematology, University Hospital of Heraklion, Crete, Greece. freda@med.uoc.gr
|
pubmed:publicationType |
Journal Article
|